Review of Current Treatment Intensification Strategies for Prostate Cancer Patients
Cancers · 28.11.2023 · 15 (23) · 5615
DOI: 10.3390/cancers15235615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.11.2023. Verfasst von Sobia Wasim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine, Gachon University, Incheon 21999, Republic of Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Priority Research Center Program Grant.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Prostate cancer (PCa) used to be one of the most common nondermatologic cancers in men that can be treated only with surgery. However, a revolutionary breakthrough came in the 1980s with the introduction of long-acting luteinizing hormone-releasing hormone (LHRH) agonists for the curative treatment of PCa. This paradigm shift contributed to the combined use of androgen deprivation therapy (ADT), chemotherapy, and radiotherapy for the treatment. The latest data highlight the use of treatment intensification (TI), i.e., combined use of radiotherapy (RT) and hormonal or drug treatments, for localized or locally advanced PCa. Indeed, the results of combined modality treatments have shown a reduction in disease-specific mortality and improved overall survival. Although TI seems promising, more research studies are warranted to confirm its efficacy. This review summarizes the latest available outcome results of pivotal trials and clinical studies on the efficacy of TI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, College of Medicine, Gachon University, Incheon 21999, Republic of Korea.
- Department of Neurology, College of Medicine, Dongguk University, Goyang 10326, Republic of Korea.
- Department of Genome Medicine and Science, College of Medicine, Gachon University, Incheon 21565, Republic of Korea.
ORCID-Profile: Sobia Wasim, Seungyoon Nam, Jaehong Kim
Förderung
- National Priority Research Center Program Grant
Zitieren
APA
Wasim, S., Park, J., Nam, S., & Kim, J. (2023). Review of Current Treatment Intensification Strategies for Prostate Cancer Patients. Cancers, 15(23), 5615. https://doi.org/10.3390/cancers15235615
Vancouver
Wasim S, Park J, Nam S, Kim J. Review of Current Treatment Intensification Strategies for Prostate Cancer Patients. Cancers. 2023;15(23):5615. doi:10.3390/cancers15235615
BibTeX
@article{Wasim2023,
author = {Wasim, Sobia and Park, Jieun and Nam, Seungyoon and Kim, Jaehong},
title = {Review of Current Treatment Intensification Strategies for Prostate Cancer Patients},
journal = {Cancers},
year = {2023},
volume = {15},
number = {23},
pages = {5615},
doi = {10.3390/cancers15235615}
}
EUVIMED